Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.

The START Center for Cancer Research ("START"), the world's largest early-phase community-based oncology site network, today announced the dosing of the first U.S. participant in Moderna's Phase 1 ...

Cadrenal Therapeutics, Inc. , a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug ...

Elie Chaillot, president and CEO of GE HealthCare International, emphasizes the role of medical imaging in addressing global ...

Experts in the field will share their insights on groundbreaking research, emerging technologies ... Advancing rare disease treatments through precision medicine AI and big data in rare disease drug ...

The future of work means small, lean, agile and AI-driven teams. And that future is now. Is your organization ready to adapt ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues, experts ...

A Google DeepMind system improves chip designs and addresses unsolved math problems but has not been rolled out to ...

AdvaMed, the MedTech Association, released its AI Policy Roadmap (the Roadmap) outlining policy priorities for Congress and the U.S. Food and Drug Administration (FDA).